BackCerevel Therapeutics Holdings Overview

Cerevel Therapeutics Holdings Current Cash

Latest current cash for CERE: $320M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$320.44M
↑ 108.32% YoYΔ $166.62M vs prior year quarter

Peer average

Loading

Cerevel Therapeutics Holdings Current Cash History

Loading

Cerevel Therapeutics Holdings vs. peers: Current Cash Comparison

Loading

Cerevel Therapeutics Holdings Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Cerevel Therapeutics Holdings (CERE) FAQ

As of the most recent data (March 2024), CERE shows a current cash of $320M. That compares with $150M in the prior-year period — up 108.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CERE's current cash is now $320M (was $150M) — a 108.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Cerevel Therapeutics Holdings is outperforming or lagging.

Tracking CERE's current cash over time shows whether Cerevel Therapeutics Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $320M That compares with $150M in the prior-year period — up 108.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Cerevel Therapeutics Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $320M) with ownership activity and broader fundamentals.

Cerevel Therapeutics Holdings's current cash is $320M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.